Global Digital Biomarker Market Growth (Status and Outlook) 2025-2031

The global Digital Biomarker market size is predicted to grow from US$ 1031 million in 2025 to US$ 42150 million in 2031; it is expected to grow at a CAGR of 85.6% from 2025 to 2031.

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.

Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.

LPI (LP Information)' newest research report, the “Digital Biomarker Industry Forecast” looks at past sales and reviews total world Digital Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Digital Biomarker sales for 2025 through 2031. With Digital Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Biomarker industry.

This Insight Report provides a comprehensive analysis of the global Digital Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Biomarker market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Biomarker.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Biomarker market by product type, application, key players and key regions and countries.

Segmentation by Type:
Passive Digital Biomarker
Active Digital Biomarker

Segmentation by Application:
Clinical Disease
Daily Health

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.